10.12
-0.16 (-1.56%)
| Penutupan Terdahulu | 10.28 |
| Buka | 10.04 |
| Jumlah Dagangan | 210 |
| Purata Dagangan (3B) | 345 |
| Modal Pasaran | 330,201,440 |
| Harga / Pendapatan (P/E TTM) | 7.53 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 Nov 2025 |
| Margin Keuntungan | -79.94% |
| Margin Operasi (TTM) | -2,318.99% |
| EPS Cair (TTM) | 1.34 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 5,556.00% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 2.33% |
| Nisbah Semasa (MRQ) | 9.00 |
| Aliran Tunai Operasi (OCF TTM) | -130.36 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -35.38 M |
| Pulangan Atas Aset (ROA TTM) | -15.49% |
| Pulangan Atas Ekuiti (ROE TTM) | -23.46% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (GB) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | PROTHENA CORPORATION PLC PROTHE | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -1.0 |
| Purata Bergerak Teknikal | 3.5 |
| Osilator Teknikal | 2.0 |
| Purata | 1.13 |
Saham Serupa
| Stok | Modal Pasaran | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| PROTHENA CORPORATION PLC PROTHE | 330 M | - | 7.53 | - |
| PHARMA MAR SA PHARMA MAR ORD SH | 16 B | 1.08% | 14.69 | - |
| ARROWHEAD PHARMACEUTICALS INC A | 4 B | - | - | - |
| GENUS PLC ORD 10P | 2 B | 0.01% | 81.55 | 3.61 |
| BASILEA PHARMACEUTICA AG BASILE | 511 M | - | - | 6.18 |
| AVACTA GROUP PLC ORD 10P | 353 M | - | - | 2.35 |
|
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer’s disease (PRX123), Neurodegeneration (PRXPRX019), and Others. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 18.99% |
| % Dimiliki oleh Institusi | 74.35% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |